↓ Skip to main content

Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential

Overview of attention for article published in Molecular Cancer, September 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
7 X users

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Published in
Molecular Cancer, September 2022
DOI 10.1186/s12943-022-01650-5
Pubmed ID
Authors

Zhengjun Lin, Yanlin Wu, Yiting Xu, Guoqing Li, Zhihong Li, Tang Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 16%
Unspecified 5 9%
Student > Master 4 7%
Student > Doctoral Student 3 5%
Researcher 3 5%
Other 6 11%
Unknown 25 45%
Readers by discipline Count As %
Medicine and Dentistry 9 16%
Biochemistry, Genetics and Molecular Biology 5 9%
Unspecified 4 7%
Agricultural and Biological Sciences 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 5 9%
Unknown 26 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2022.
All research outputs
#7,158,095
of 23,660,057 outputs
Outputs from Molecular Cancer
#524
of 1,785 outputs
Outputs of similar age
#132,314
of 434,754 outputs
Outputs of similar age from Molecular Cancer
#15
of 43 outputs
Altmetric has tracked 23,660,057 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,785 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,754 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.